Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06260514 · ClinicalTrials.gov registry record · Phase 1

Study of APR-1051 in Patients With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by Aprea Therapeutics.

Recruiting
Registry status
Phase 1
Development phase
90
Enrollment target
3
Study locations

NCT06260514 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by Aprea Therapeutics. The registered enrollment target is 90 participants, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (53% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06260514, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by Aprea Therapeutics.

RECRUITING
Registry status
Phase 1
Development phase
90 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to assess the safety and effectiveness of APR-1051 through the performance of a Phase 1, open-label, safety, PK, and preliminary efficacy study of oral APR-1051 in patients with advanced solid tumors.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG APR-1051

Study Locations (3)

Texas

  • MD Anderson Cancer Center (MDACC) - Houston
  • NEXT Oncology -Dallas - Irving
  • NEXT Oncology -San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-06-13
Est. Completion 2028-06
Phase Phase 1

Sponsor

Aprea Therapeutics

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06260514

The ClinicalTrials.gov registry entry for NCT06260514 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (53% lower). The listed sponsor is Aprea Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which APR-1051 is the first listed.

NCT06260514 reports 3 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06260514 about?

NCT06260514 is a clinical study titled "Study of APR-1051 in Patients With Advanced Solid Tumors". The purpose of this study is to assess the safety and effectiveness of APR-1051 through the performance of a Phase 1, open-label, safety, PK, and preliminary efficacy study of oral APR-1051 in patients with advanced solid tumors.

What is the current status of trial NCT06260514?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2024-06-13. Estimated completion is 2028-06.

What conditions does trial NCT06260514 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT06260514?

The interventions under investigation include: APR-1051 (DRUG).

Who is sponsoring clinical trial NCT06260514?

This trial is sponsored by Aprea Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06260514 being conducted?

This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.